Last updated on: 10/22/2009 | Author:

Kirk Shepard, MD Biography

Former Vice President of Medical and Scientific Affairs at Takeda Pharmaceuticals North America, Inc.
Pro to the question "Should Marijuana Be a Medical Option?"

“With chemotherapy, I would say yes, there are some studies that show that marijuana is effective.”

“Marinol: The Little Synthetic That Couldn’t,” High Times Magazine, July 1994

Theoretical Expertise Ranking:
     Key Experts
Physicians [Physicians are the "key experts" in the medical marijuana debate because the issue is thought by many to be ultimately based on the medical value and risks of marijuana, and Physicians, with their training and clinical work, should (at least in theory) have the best knowledge of marijuana's medical value and risks.] [Note: Key Experts definition varies by sites that have this designation.]
Involvement and Affiliations:
  • Senior Vice President, Global Medical Affairs Oncology, Eisai
  • President, Medical Affairs Professional Society
  • Former Vice President, Medical and Scientific Affairs, Takeda Pharmaceuticals North America, Inc.
  • Former Vice President, Clinical and Scientific Affairs, Boehringer Ingelheim Pharmaceuticals, Inc.
  • Former Senior Vice President of Business Unit/Hospital Strategy, Roxane Laboratories, Inc.
  • Former Vice President, Medical Affairs, Roxane Laboratories, Inc.
  • Board-certified in oncology and hematology
  • Residency, Internal Medicine, Case Western Reserve University
  • Fellowship, Hematology and Oncology, University of Chicago Hospitals and Clinics
  • MD, University of Cincinnati Medical School
  • BA, Cornell University
  • None found